Abstrakti
Bone is one of the most frequently targeted organs in metastatic cancers including the breast. Breast cancer bone metastasis often results in devastating outcomes as limited treatment options are currently available. Therefore, innovative methods are needed to provide earlier detection and thus better treatment and prognosis. Here, we present a new approach to model bone-like microenvironments to detect invasion and extravasation of breast cancer cells using invasion/chemotaxis (IC-) and extravasation (EX-) chips, respectively. Our results show that the behaviors of MDA-MB-231 breast cancer cells on IC- and EX-chip models correlate with their in vivo metastatic potential. Our culture model constitutes cell lines representing osteoblasts, bone marrow stromal cells, and monocytes embedded in three-dimensional (3D) collagen I-based extracellular matrices of varying composition and stiffness. We show that collagen I offers a better bone-like environment for bone cells and matrix composition and stiffness regulate the invasion of breast cancer cells. Using in situ contactless rheological measurements under cell culture conditions, we show that the presence of cells increased the stiffness values of the matrices up to 1200 Pa when monitored for five days. This suggests that the cellular composition has a significant effect on regulating matrix mechanical properties, which in turn contribute to the invasiveness. The platforms we present here enable the investigation of the underlying molecular mechanisms in breast cancer bone metastasis and provide the groundwork of developing preclinical tools for the prediction of bone metastasis risk.
| Alkuperäiskieli | Englanti |
|---|---|
| Artikkeli | e0309285 |
| Julkaisu | PLoS ONE |
| Vuosikerta | 19 |
| Numero | 10 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - lokak. 2024 |
| OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
O.Y.O and D.P.O. received the funding from the Scientific and Technological Research Council of Turkiye (TUBITAK), 115E057 N.N. received the funding from the Research Council of Finland (No. 352900) B.F.Y. received a short-term fellowship from the European Molecular Biology Organization (EMBO), 8509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Joan Massagu\u00E9 and Memorial Sloan Kettering Cancer Center for providing MDA-MB-231 LM2 and MDA-MB-231 1833-BoM; Engin \u00D6z\u00E7ivici for providing hFOB 1.19, SaOs-2, and D1 ORL UVA; H. Cumhur Tekin for providing U937 cell lines.
| Rahoittajat | Rahoittajan numero |
|---|---|
| Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | 115E057 |
| Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | |
| Research Council of Finland | 352900 |
| Research Council of Finland | |
| European Molecular Biology Organization | MDA-MB-231 1833-BoM, SaOs-2 |
| European Molecular Biology Organization |
YK:n kestävän kehityksen tavoitteet
Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:
-
SDG 3 – Hyvä terveys ja hyvinvointi
Julkaisufoorumi-taso
- Jufo-taso 1
!!ASJC Scopus subject areas
- General
Sormenjälki
Sukella tutkimusaiheisiin 'Invasion/chemotaxis- and extravasation-chip models for breast cancer bone metastasis'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Siteeraa tätä
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver